Tarsus Pharmaceuticals, Inc.

NASDAQ:TARS

52.91 (USD) • At close December 20, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32018 Q22018 Q1
Omzet 48.11840.81327.61413.0761.87115.2772.510015.2770.5390.3381.2422.01733.43200000000
Kosten van de omzet 3.2423.0041.6541.2160.3770.3160.2550.410.9120.5220.0338.0140.0650.7371.29700000000
Brutowinst 44.87637.80925.9611.861.49414.9612.2459.6-10.91214.7550.506-7.6761.17521.2832.13500000000
Brutowinstmarge 0.9330.9260.940.9070.7990.9790.8980.9600.9660.9391.0710.9480.9670.96100000000
Onderzoek- en ontwikkelingskosten 12.12812.31912.06613.30512.10512.54612.35610.02810.9129.60312.0818.03810.2097.20416.2617.5877.9911.7371.5120.6970.3990.2250.225
Algemene en administratieve kosten 058.792065.69530.32420.27515.09614.63311.99410.3767.9466.7726.6716.7945.163.892.151.5260.6060.3870.2340.1120.112
Verkoop- en marketingkosten 000-22.690000000000000000000
Verkoop-, algemene en administratieve kosten 57.9158.79251.57843.00530.32420.27515.09614.63311.99410.3767.9466.7726.6716.7945.163.892.151.5260.6060.3870.2340.1120.112
Overige kosten 000.605-0.013-0.048-0.0470.006-0.05-0.0070.1060.037-0.0050.005-0.039-0.0344.28200000-0.675-0.675
Bedrijfskosten 70.03871.11163.64456.3142.42932.82127.45224.66122.90619.97920.02714.8116.8813.99821.42111.47710.1413.2632.1181.0840.633-0.338-0.338
Bedrijfsresultaat -25.162-33.302-37.684-44.45-40.935-32.821-24.952-15.061-22.906-5.224-19.521-14.448-15.7057.28210.714-11.477-10.141-3.263-2.118-1.084-0.633-0.338-0.338
Bedrijfsresultaat ratio -0.523-0.816-1.365-3.399-21.879-2.148-9.981-1.5060-0.342-36.217-42.746-12.6650.3310.3200000000
Totaal overige inkomsten en kosten netto 1.7420.0121.9532.5481.7871.3971.5331.4620.39-0.519-0.716-0.349-0.333-0.908-0.0250.010.0040.0130.161-0.328-0.0480.0080.008
Inkomen voor belasting -23.42-33.29-35.731-41.902-40.935-31.424-23.419-13.599-22.516-5.743-20.237-14.797-16.0386.37410.689-11.467-10.137-3.25-1.957-1.412-0.681-0.33-0.33
Inkomen voor belasting ratio -0.487-0.816-1.294-3.204-21.879-2.057-9.368-1.360-0.376-37.545-43.778-12.9340.290.3200000000
Belastingkosten 00-0.2730.398-1.787-27.078-1.533-0.521-0.0050.5190.0010.054-0.3410.0290.313-0.0010.001000.3280.04800
Nettowinst -23.42-33.29-35.731-41.902-39.148-31.424-21.886-13.078-22.511-6.262-20.238-14.851-15.6976.34510.376-11.467-10.138-3.25-1.957-1.412-0.681-0.33-0.33
Nettowinstmarge -0.487-0.816-1.294-3.204-20.924-2.057-8.754-1.3080-0.41-37.547-43.938-12.6590.2880.3100000000
WPA (Winst Per Aandeel) -0.61-0.88-1.01-1.31-1.28-1.17-0.82-0.49-0.84-0.26-0.98-0.72-0.760.310.51-0.56-0.54-0.3-0.18-0.13-0.063-0.077-0.077
Verwaterde WPA -0.61-0.88-1.01-1.31-1.28-1.17-0.82-0.49-0.84-0.26-0.98-0.72-0.760.290.47-0.53-0.54-0.3-0.18-0.13-0.063-0.077-0.077
EBITDA -20.675-30.942-34.478-40.566-37.921-30.293-22.48-12.688-21.672-5.107-19.767-14.408-15.8647.40710.778-11.437-10.117-3.246-2.103-1.065-0.624-0.329-0.329
EBITDA ratio -0.43-0.758-1.365-3.373-21.879-1.994-9.061-1.2980-0.311-35.33-41.574-12.3190.3760.32200000000